These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6758457)

  • 21. Alteration of Fc-receptor phenotype and proliferative capacity of Fc-IgG-receptor positive lymphocytes through interaction with soluble immune complexes of patients with SLE or RA.
    Thien M; Renger D; Deicher H; Pichler WJ
    Rheumatol Int; 1985; 5(3):127-32. PubMed ID: 3160099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-specific cellular immunity in type I and type II diabetes.
    Fövenyi J; Tótpál K; Thaisz E; Garam T
    Exp Clin Endocrinol; 1984 Apr; 83(2):203-6. PubMed ID: 6539221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in the immunologic profile of newly-diagnosed diabetic patients during the first year of the disease].
    Pizzul MG; Betterle C; De Campo C; Tonini G; Marinoni S; Pocecco M
    Pediatr Med Chir; 1988; 10(5):481-5. PubMed ID: 3071777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immune response in individuals with HLA-DR specificities conferring susceptibility to insulin-dependent diabetes--a hypothesis.
    Papadopoulos G; Lernmark A
    Diabetes Res; 1984 May; 1(1):3-11. PubMed ID: 6085044
    [No Abstract]   [Full Text] [Related]  

  • 28. Heterogeneity of human lymphocyte Fc receptors: studies using heat-aggregated and antigen-complexed IgG from human, rabbit, guinea pig, horse and goat.
    Gormus BJ; Vessella RL; Martin LN; Kaplan ME
    Comp Immunol Microbiol Infect Dis; 1982; 5(4):483-99. PubMed ID: 7172622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte subsets and immune complexes in long-standing diabetic patients: relation with the presence of microangiopathy.
    Andreani D; Di Mario U; Zuccarini O; Franco M; Sensi M; Iavicoli M; Pozzilli P
    Immunol Lett; 1984; 8(1):17-21. PubMed ID: 6611302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune complex-mediated inhibition of lymphocyte Fc-gamma receptors in the plasma of patients with type 1 (insulin-dependent) diabetes mellitus: association with anti-ssDNA antibodies.
    Guarnotta G; Triolo G
    Clin Immunol Immunopathol; 1990 Feb; 54(2):228-36. PubMed ID: 2136821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitus.
    Pozzilli P; Zuccarini O; Sensi M; Spencer KM; Bottazzo G
    Biomed Biochim Acta; 1984; 43(5):621-5. PubMed ID: 6236800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet cell antibodies and cellular immunity in human diabetes.
    Papadopoulos G; Lernmark A
    Behring Inst Mitt; 1984 Jul; (75):50-7. PubMed ID: 6435595
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of resident lymphocytes in human pancreatic islets.
    Radenkovic M; Uvebrant K; Skog O; Sarmiento L; Avartsson J; Storm P; Vickman P; Bertilsson PA; Fex M; Korgsgren O; Cilio CM
    Clin Exp Immunol; 2017 Mar; 187(3):418-427. PubMed ID: 27783386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.
    Tun RY; Peakman M; Alviggi L; Hussain MJ; Lo SS; Shattock M; Pyke DA; Bottazzo GF; Vergani D; Leslie RD
    BMJ; 1994 Apr; 308(6936):1063-8. PubMed ID: 8173426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dynamics of disorders of cellular and humoral immunity parameters in patients with insulin-dependent diabetes mellitus].
    Khaitov RM; Dedov II; Brykova SV; Smirnova OM; Esenin VI; Andreev VN; Nikonova TV; Kireeva AP; Gudima GO; Alekseev LP
    Probl Endokrinol (Mosk); 1992; 38(2):8-12. PubMed ID: 1513781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of T-cell-mediated regulation of antibody production by interaction with specific immune complexes.
    Clough JD; Calabrese LH; Budervic SA
    Clin Lab Med; 1988 Jun; 8(2):337-49. PubMed ID: 3284700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearance.
    von Herrath MG; Coon B; Wolfe T; Chatenoud L
    J Immunol; 2002 Jan; 168(2):933-41. PubMed ID: 11777992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.